Benefit of Roflumilast Therapy Added to Salmeterol in Patients With Varying Chronic Obstructive Pulmonary Disease Severity

Authors :: Fernando J. Martinez
Andrew McIvor
Thomas Larsson
Manja Brose
Udo-Michael Goehring
Source :: Chest. 138:467A
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Pulmonary and Respiratory Medicine
medicine.medical_specialty
business.industry
Internal medicine
medicine
Pulmonary disease
In patient
Salmeterol
Cardiology and Cardiovascular Medicine
Critical Care and Intensive Care Medicine
business
Roflumilast
medicine.drug

Full Text Access

Tools